Atherosclerosis, Ischemia, and Anticancer Drugs

The heart is affected by cardiotoxicity of anticancer drugs. Myocardium, pericardium and endocardium can be affected. Besides these coronary arteries can be affected by accelerated atherosclerosis. Various pathogenic mechanisms have been proposed that underlie the ischemic complications of anticance...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Shailesh, Singh, Katyayni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445146/
https://www.ncbi.nlm.nih.gov/pubmed/34584624
http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_45_20
_version_ 1784568594943705088
author Singh, Shailesh
Singh, Katyayni
author_facet Singh, Shailesh
Singh, Katyayni
author_sort Singh, Shailesh
collection PubMed
description The heart is affected by cardiotoxicity of anticancer drugs. Myocardium, pericardium and endocardium can be affected. Besides these coronary arteries can be affected by accelerated atherosclerosis. Various pathogenic mechanisms have been proposed that underlie the ischemic complications of anticancer drugs. In this review we discuss the atherosclerotic and ischemic complications of anticancer drugs.
format Online
Article
Text
id pubmed-8445146
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-84451462021-09-27 Atherosclerosis, Ischemia, and Anticancer Drugs Singh, Shailesh Singh, Katyayni Heart Views Review Article The heart is affected by cardiotoxicity of anticancer drugs. Myocardium, pericardium and endocardium can be affected. Besides these coronary arteries can be affected by accelerated atherosclerosis. Various pathogenic mechanisms have been proposed that underlie the ischemic complications of anticancer drugs. In this review we discuss the atherosclerotic and ischemic complications of anticancer drugs. Wolters Kluwer - Medknow 2021 2021-08-19 /pmc/articles/PMC8445146/ /pubmed/34584624 http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_45_20 Text en Copyright: © 2021 Heart Views https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Singh, Shailesh
Singh, Katyayni
Atherosclerosis, Ischemia, and Anticancer Drugs
title Atherosclerosis, Ischemia, and Anticancer Drugs
title_full Atherosclerosis, Ischemia, and Anticancer Drugs
title_fullStr Atherosclerosis, Ischemia, and Anticancer Drugs
title_full_unstemmed Atherosclerosis, Ischemia, and Anticancer Drugs
title_short Atherosclerosis, Ischemia, and Anticancer Drugs
title_sort atherosclerosis, ischemia, and anticancer drugs
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445146/
https://www.ncbi.nlm.nih.gov/pubmed/34584624
http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_45_20
work_keys_str_mv AT singhshailesh atherosclerosisischemiaandanticancerdrugs
AT singhkatyayni atherosclerosisischemiaandanticancerdrugs

Ejemplares similares